-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX PHARMACEUTICALS (NASDAQ:NRXP) ANNOUNCES FDA BIOEQUIVALENCE DETERMINATION BY OFFICE OF GENERIC DRUGS FOR NRX’S PRESERVATIVE-FREE KETAMINE APPLICATION

Reuters·03/17/2026 11:00:02

Please log in to view news